QQ客服 官方微博 反馈留言

	RLA8-A New and Highly Effective Quadruple PPAR-alpha/gamma/delta and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis
	Li, Meng Hua; Chen, Wei; Wang, Li Li; Sun, Jia Lin; Zhou, Lei; Shi, Yu Cong; Wang, Chu Han; Zhong, Bo Hua; Shi, Wei Guo; Guo, Zhong 更多
刊名	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
	2019
卷号	369期号:1页码:67-77
DOI	10.1124/jpet.118.255216
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4529752
专题	山东大学
作者单位	1.Shandong Univ, Natl Glycoengn Res Ctr, Jinan, Shandong, Peoples R China. 2.Shandong Univ,
推荐引用方式 GB/T 7714	Li, Meng Hua,Chen, Wei,Wang, Li Li,et al. RLA8-A New and Highly Effective Quadruple PPAR-alpha/gamma/delta and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2019,369(1):67-77.
APA	Li, Meng Hua.,Chen, Wei.,Wang, Li Li.,Sun, Jia Lin.,Zhou, Lei.,...&Guo, Zhong 更多.(2019).RLA8-A New and Highly Effective Quadruple PPAR-alpha/gamma/delta and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,369(1),67-77.
MLA	Li, Meng Hua,et al."RLA8-A New and Highly Effective Quadruple PPAR-alpha/gamma/delta and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis".JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 369.1(2019):67-77.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。